Stephen A Trowbridge insider trades: Angiodynamics (ANGO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Stephen reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | ANGO | ↓ Sell | 25,335 | $12.26 | $311K | Direct | Oct 30, 2026 (1d) |
| Oct 13, 2025 | ANGO | ↑ Buy | 890 | $11.16 | $10K | Direct | Oct 14, 2025 (1d) |
| Oct 8, 2024 | ANGO | ↑ Buy | 1,700 | $5.86 | $10K | Direct | Oct 8, 2024 (0d) |
| Oct 12, 2022 | ANGO | ↑ Buy | 1,083 | $13.82 | $15K | Direct | Oct 12, 2022 (0d) |
| Jan 12, 2022 | ANGO | ↑ Buy | 1,000 | $22.64 | $23K | Direct | Jan 12, 2022 (0d) |
| Aug 11, 2020 | ANGO | ↑ Buy | 1,013 | $9.38 | $10K | Direct | Aug 12, 2020 (1d) |
| Apr 25, 2016 | ANGO | ↓ Sell | 12,940 | $12.30 | $159K | Direct | Apr 25, 2016 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Stephen A Trowbridge's insider trades
Stephen A Trowbridge is EVP and CFO at Angiodynamics (ANGO). Since Apr 25, 2016, Stephen has reported 5 open-market purchases worth $67K and 2 sales worth $470K on SEC Form 4. In the last 12 months: 1 sale ($311K).
Their filings also include shares withheld for taxes (38 filings), grants and awards (16 filings), option exercises (11 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANGO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.